Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04973163
Title A Study to Test Different Doses of BI 1823911 Alone and Combined With Other Medicines in People With Different Types of Advanced Cancer With KRAS Mutation
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications

colorectal cancer

lung non-small cell carcinoma

cholangiocarcinoma

lung adenocarcinoma

pancreatic cancer

Advanced Solid Tumor

Therapies

BI 1823911 + Midazolam

BI 1701963 + BI 1823911

Age Groups: senior | adult
Covered Countries USA | ESP | BEL


No variant requirements are available.